Intresseorganisationer

Projektets/aktivitetens namn:

IFPA Partnership Program 2021-2024 with Flagship Programs: WPD, Forum and Accelerator + funding for Website 2021

Tidplan/datum:

Startdatum: 2021-07-01
Slutdatum: 2024-06-30

Läkemedelsföretag:

UCB Pharma AB (ansvarar för innehållet i denna text)

Samarbetspartner:

IFPA - International Federation of Psoriasis Associations

Projektbeskrivning:

Through the partnership program and its Flagship programs plus the funding for IFPA Website, UCB enables IFPA’s important mission to unite, strengthen and lead the global psoriatic disease community.

Ekonomi – Beskrivning:

in total 361.000 Euro Upon signature of this agreement Partnership program, flagship programs and website funding 2021-2022: 141 000 EUR July 1, 2022 Partnership program and flagship programs, 2022-2023: 110 000 EUR July 1, 2023 Partnership program and flagship programs, 2023-2024:110 000 EUR

Övrigt:

Kontaktpersoner:

UCB Pharma AB, Karin Götte Idolor, 0762170073, karin.gotteidolor@ucb.com
IFPA - International Federation of Psoriasis Associations, Frida Dunger Johnsson, 0760273222, info@ifpa-pso.com

Länkar till mer information:

www.ifpa-pso.com www.globalpsoriasiscoalition.org

Bifogade filer:

Sidan skapades:

2021-10-25 17:41:36

Senaste uppdatering: